GlassScriptPhysician profile
Jason C Harrill
NPI 1972563955
$16,077.13
in general payments reported to CMS, 2019-2025
57 companies · $4,079 in 2025
The $4,079 reported for 2025 was more than what 92% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,293 · 2020: $537 · 2021: $3,588 · 2022: $467 · 2023: $1,226 · 2024: $4,887 · 2025: $4,079.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $6,582 · Food and Beverage: $2,381 · Travel and Lodging: $1,229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $6,581.61 |
| Food and Beverage | $2,380.81 |
| Travel and Lodging | $1,229.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fusion Orthopedics USA, LLC | $5,154.34 | 2024-2025 | Lapilock and Lapidus U Plate, Lapilock, Polylock |
| Treace Medical Concepts, INC. | $1,953.05 | 2021-2025 | |
| Fusion Orthopedics, LLC. | $1,427.27 | 2024 | Lapilock and Lapidus U Plate |
| Vaporox, INC. | $1,155.98 | 2020-2021 | |
| Smith+Nephew, INC. | $791.95 | 2019-2025 | Salto Talaris Total Ankle Prosthesis, Cadence, Bone Anchors With Arthroscopic Delivery System |
| Paragon 28, INC. | $698.52 | 2021 | |
| Abbvie INC. | $608.97 | 2021-2025 | |
| Medical Device Business Services, INC. | $428.08 | 2025 | Motoband |
| Musculoskeletal Transplant Foundation INC. | $342.14 | 2019-2021 | |
| Polynovo North America LLC | $336.88 | 2022-2025 | Novosorb Btm |
| Bioventus LLC | $271.61 | 2020-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Ortho Solutions INC | $249.80 | 2019 | |
| Horizon Therapeutics Plc | $192.97 | 2019-2023 | Krystexxa |
| Organogenesis INC. | $185.92 | 2019-2021 | |
| Orthofix Medical, INC. | $162.96 | 2019-2025 | Physio-Stim |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $155.47 | 2024 | Qutenza |
| Kci USA, INC. | $129.38 | 2019-2023 | V.A.C. Veraflo, Prevena, Promogran Prisma |
| Tactile Systems Technology INC | $127.87 | 2019-2025 | Flexitouch Plus, Nimbl |
| Heron Therapeutics, INC. | $123.42 | 2021 | |
| Depuy Synthes Sales INC. | $117.46 | 2019-2025 | Motoband, Na, Speedtrap |
| Anika Therapeutics, INC. | $101.45 | 2021 | |
| Paratek Pharmaceuticals, INC. | $98.56 | 2021-2025 | Nuzyra |
| Abbott Laboratories | $73.87 | 2019 | |
| Amgen INC. | $71.81 | 2025 | Krystexxa |
| Alfasigma USA, INC. | $69.79 | 2020-2022 | |
| Stryker Corporation | $68.65 | 2021-2023 | Citrefix |
| Arteriocyte Medical Systems, INC. | $66.22 | 2021-2022 | |
| Djo, LLC | $63.67 | 2021-2022 | |
| Integra Lifesciences Corporation | $61.63 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Urgo Medical North America, LLC | $59.37 | 2025 | Urgok2 |
| Advanced Oxygen Therapy INC. | $44.91 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Polarityte, INC. | $44.53 | 2019 | |
| Melinta Therapeutics, LLC | $41.62 | 2019-2021 | |
| Sandoz INC. | $41.15 | 2019 | |
| Kerecis Limited | $40.19 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $40.13 | 2019-2020 | |
| Biotissue Holdings INC. | $38.69 | 2021-2022 | |
| Misonix INC | $36.33 | 2019-2021 | |
| Crossroads Extremity Systems, LLC | $33.66 | 2019 | |
| Aap Implants INC | $28.99 | 2021 | |
| Nabriva Therapeutics, Plc | $26.50 | 2021-2022 | |
| Lifenet Health | $26.24 | 2024 | Theragenesis Wound Matrix |
| Nevro Corp. | $26.09 | 2022 | |
| Impactortho, INC. | $25.71 | 2024 | |
| Aroa Biosurgery Incorporated | $23.80 | 2025 | |
| Extremity Medical | $22.60 | 2021 | |
| Bard Peripheral Vascular, INC. | $22.47 | 2024 | Rotarexs 6 F X 135 Cm |
| Next Science LLC | $22.29 | 2023 | Xperience, Surgx, Blastx |
| Covidien LP | $21.45 | 2020 | |
| Ibsa Pharma INC. | $21.13 | 2023 | Tirosint, Licart |
| Merck Sharp & Dohme LLC | $18.30 | 2019 | |
| Mayne Pharma Commercial LLC | $16.91 | 2021 | |
| Goode Surgical INC | $13.75 | 2020 | |
| Medela LLC | $13.42 | 2021 | |
| Trice Medical, INC. | $12.91 | 2022 | |
| Osiris Therapeutics INC. | $12.45 | 2019 | |
| Arthrosurface Incorporated | $11.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$221,736.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Harrill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.